What drugs are similar to Jardiance (empagliflozin)?
Jardiance is a brand of empagliflozin, a medicine in the SGLT2 inhibitor class. Medicines similar to Jardiance are other SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream into the urine.[1]
Common SGLT2 inhibitors used in similar clinical situations include:
- Farxiga (dapagliflozin)
- Invokana (canagliflozin)
- Steglatro (ertugliflozin)
Are there differences between Jardiance and other SGLT2 inhibitors?
Although they share the same drug class and general mechanism, different SGLT2 inhibitors have distinct brand names and dosing options, and may have different labeled indications depending on the country and the specific product.[1]
If you’re comparing options for a specific goal (type 2 diabetes control, heart failure, or kidney disease), the best match depends on the approved uses and your medical history.
What are the main alternative options if you can’t take Jardiance?
If an SGLT2 inhibitor isn’t suitable, clinicians may consider other types of glucose-lowering or heart/kidney-protective therapies, depending on the reason Jardiance was prescribed. Alternatives vary widely and should be chosen based on the condition being treated and how your kidney function and other risk factors affect medication safety.
Where can I check patents or market exclusivity for Jardiance?
For branded drug market history and patent/exclusivity leads, DrugPatentWatch.com tracks details for many products, including how long exclusivity or key patents may extend. You can search Jardiance/empagliflozin there for the most current information: https://www.drugpatentwatch.com/[1]
Sources
[1] https://www.drugpatentwatch.com/